EverHint – EMA 10/30 Crossover, SMA 20/50 Crossover, EMA 10 + Price + MACD – Top 20 Buy and Top 10 Sell Signals for May 19, 2026

Market Context

Equity markets are experiencing a modest broad-based pullback, with all three major indices declining between 0.65% and 0.83% on the session. This coordinated selling suggests a mild risk-off tone rather than sector-specific pressure, and the uptick in the VIX to 18.07 — while still within a historically moderate range — signals that options markets are pricing in slightly elevated uncertainty. For momentum-based strategies like EMA and SMA crossovers, this environment introduces some noise into trend signals, as short-term moving averages may begin to flatten or curl lower, increasing the likelihood of false crossovers if the pullback extends further.

The VIX reading near 18 sits in a transitional zone — not low enough to confirm complacency, but not elevated enough to signal a high-fear regime. This level tends to produce moderate intraday swings that can whipsaw shorter-period signals like the EMA 10/30 crossover, while slightly longer configurations such as SMA 20/50 may offer more reliable directional reads. The MACD-based strategy will be particularly sensitive here, as declining price momentum across indices could trigger bearish histogram shifts, adding confirmation weight to any emerging sell signals but also risking premature entries if the dip proves shallow and short-lived.

Healthcare's emergence as the top signal-generating sector aligns well with the current risk-off rotation, as defensive sectors historically attract capital during broad market softness. This rotation dynamic lends additional credibility to signals firing within that sector, since price action there may be driven by genuine institutional positioning rather than broad market momentum. Traders using crossover strategies should weigh Healthcare signals with higher conviction in this environment, while remaining cautious about signals in more cyclical or growth-oriented sectors where the negative market tone could undermine follow-through.

EMA 10/30 Crossover

Detects fresh crossovers between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30), generating both buy and sell signals. Uses two EMAs instead of EMA + SMA, making it more responsive to price changes and better suited for capturing short-to-medium term momentum shifts.

Entry Criteria:

• Buy: EMA10 crosses above EMA30
• Sell: EMA10 crosses below EMA30
• Minimum ADV: $40M (liquidity filter)
• Earnings buffer: 7 days pre/post earnings
• Fresh crossover: Detected on today's close

Holding period: 1-4 weeks | Risk level: Medium

🟢 Buy Signals (10 of 14)

Ranked by RSI (lower RSI for buy signals = more oversold)

🔴 Sell Signals (5 of 60)

SMA 20/50 Crossover

Detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50). Uses two SMAs, making it more stable and less prone to false signals compared to EMA-based strategies. Well-suited for identifying medium-term trend changes with higher reliability.

Entry Criteria:

• Buy: SMA20 crosses above SMA50
• Sell: SMA20 crosses below SMA50
• Minimum ADV: $40M (liquidity filter)
• Earnings buffer: 7 days pre/post earnings
• Fresh crossover: Detected on today's close

Holding period: 2-6 weeks | Risk level: Medium

🟢 Buy Signals (2 of 2)

Ranked by RSI (lower RSI = more oversold for buy signals)

🔴 Sell Signals (5 of 6)

EMA 10 + Price + MACD

Experimental strategy combining price crossing above EMA10 from below with MACD Line crossing above Signal Line from below. Both conditions must occur on the same day for a signal, providing double confirmation and higher-quality setups.

Entry Criteria:

• Buy: Price > EMA10 AND MACD line crosses above signal line
• Sell: Price < EMA10 AND MACD line crosses below signal line
• Minimum ADV: $40M (liquidity filter)
• Earnings buffer: 7 days pre/post earnings
• Fresh signal: All conditions met on today's close

Holding period: 1-3 weeks | Risk level: Medium-High

🟢 Buy Signals (8 of 8)

Ranked by RSI (lower RSI = more oversold for buy signals)

Field Notes

Sector concentration: Healthcare (19), Industrials (18), Basic Materials (14)

Near-term earnings: AGYS (Agilysys, Inc.) report within 7 days. Higher volatility risk.

Data coverage: 0.0% insider, 0.0% congressional, 3.3% earnings, 8.9% news

Vlad's Take

Today's signals: Strong sector concentration in Healthcare (19 signals) suggests sector-specific rotation.

Trading tips for this strategy:

• Entry timing: Enter on pullback after crossover or at crossover close price
• Position sizing: Start with 2-3% of portfolio per signal (swing trade size)
• Stop loss: Below recent swing low for buys, above recent swing high for sells
• Take profit: 5-10% target for swings, or trail stop at EMA10
• Time stop: Exit if crossover reverses within 1-2 weeks (failed signal)

Risk warning: EMA crossovers generate more signals but higher whipsaw risk in ranging markets. Use with trend filter (price vs SMA200)

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/

📢 If you found this useful, a quick like, share, or subscribe keeps EverHint moving forward.